Management of patients with advanced HCC receiving atezolizumab/bevacizumab: Take care of cirrhosis!

Hepatology. 2024 Aug 5. doi: 10.1097/HEP.0000000000001047. Online ahead of print.

Jean-Charles Nault^{1

2

3}, Massimo Iavarone^{4

5}

¹ Cordeliers Research Center, Sorbonne University, Inserm, Paris Cité University, "Functional Genomics of Solid Tumors" team, Ligue Nationale Contre le Cancer accredited team, Labex OncoImmunology, Paris, France.
² Liver Unit, Avicenne Hospital, APHP, Bobigny, France.
³ University Sorbonne Paris Nord, Bobigny, France.
⁴ Foundation IRCCS Ca' Granda Ospedale Maggiore Policlinico, Division of Gastroenterology and Hepatology, Milan, Italy.
⁵ CRC "A. M. and A. Migliavacca" Center for Liver Disease, Department of Pathophysiology and Transplantation, University of Milan, Milan, Italy.

No abstract available